Home » Newsletters » BioWorld

BioWorld

March 29, 2000

View Archived Issues

Achillion Raises $17M In First Financing For Antiviral Efforts

Analysts: Stock Downswing Not Likely A Lasting Trend

Other News To Note

Two Firms At IPO Cash Drawer: Allos, $90M; IntraBiotics, $112M

Long-term Results Address Issues With QLT's Visudyne

Onyx Files For $46M Offering For Anticancer Drug Research

Molecular Biologists Use Body's Own Cells and Genes to Generate Novel Drugs, Regenerate Injuries

Accelerated Approval: Working With The FDA To Benefit Patients